Intrathecal Magnesium for Same-day-surgery

Summary

Intrathecal Magnesium for Same-day-surgery is a clinical trial^[1].

Key Facts

• Intrathecal Magnesium for Same-day-surgery is in the country of Spain^[2].
• Intrathecal Magnesium for Same-day-surgery's instance of is recorded as clinical trial^[3].
• Intrathecal Magnesium for Same-day-surgery's start time is recorded as +2013-04-30T00:00:00Z^[4].
• Intrathecal Magnesium for Same-day-surgery's end time is recorded as +2013-12-31T00:00:00Z^[5].
• Intrathecal Magnesium for Same-day-surgery's main subject is recorded as syndrome^[6].
• Intrathecal Magnesium for Same-day-surgery's number of participants is recorded as {'unit': '1', 'amount': '+21'}^[7].
• Intrathecal Magnesium for Same-day-surgery's title is recorded as Intrathecal Magnesium Associated to Lidocaine Decreases the Incidence of the Transitory Neurologic Syndrome Following Same-day-surgery^[8].
• Intrathecal Magnesium for Same-day-surgery's short name is recorded as MAGLIDIT^[9].
• Intrathecal Magnesium for Same-day-surgery's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Intrathecal Magnesium for Same-day-surgery's ClinicalTrials.gov ID is recorded as NCT01794247^[11].
• Intrathecal Magnesium for Same-day-surgery's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[12].
• Intrathecal Magnesium for Same-day-surgery's research intervention is recorded as magnesium sulfate^[13].
• Intrathecal Magnesium for Same-day-surgery's clinical trial phase is recorded as phase III clinical trial^[14].
• Intrathecal Magnesium for Same-day-surgery's research site is recorded as Hospital General Universitario de Ciudad Real^[15].
• Intrathecal Magnesium for Same-day-surgery's study type is recorded as interventional study^[16].